🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

European stocks rise on cooling inflation, healthcare boost

Published 31/07/2023, 08:32
© Reuters. FILE PHOTO-The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, July 28, 2023. REUTERS/Staff
DE40
-
IT40
-
BAYGN
-
NOVOb
-
DGE
-
STOXX
-

By Sruthi Shankar, Amruta Khandekar and Shristi Achar A

(Reuters) -European shares ended higher on Monday, helped by gains in healthcare stocks and a report showing euro zone inflation eased further in July, though upbeat growth data tempered optimism about a rate hike pause.

The pan-European STOXX 600 ended up 0.1%. The index climbed 2% in July, gaining for the second month in a row.

Data showed euro zone consumer prices grew by 5.3% this month versus 5.5% in June, extending a downtrend that started in the autumn. Excluding energy and unprocessed food, prices increased by 6.6% after a 6.8% rise a month earlier.

Another set showed the bloc returned to growth in the second quarter, though Germany, the euro zone's biggest country, registered no growth and Italy suffered a contraction.

"The news in Europe is a bit more mixed (with) the preliminary data in Italy coming in much weaker than expected, although the eurozone is not doing too badly," said Andrea Cicione, head of research at TS Lombard.

"The picture is not as encouraging as the US and so the markets are trying to figure out what matters most."

Inflation has been on a downtrend in the United States while the economy has also shown resilience, staving off fears of a deep recession and fuelling hopes that the Fed has reached the end of its rate hikes.

Markets have received a further boost this month from speculation that the ECB could also refrain from tightening further as well some upbeat earnings.

The energy sector was up 1.2% as UK-listed oil and gas firms including Harbour Energy (LON:HBR) strengthened on Britain's plans to grant new North Sea licences.

Healthcare stocks led gains, with Novo Nordisk (CSE:NOVOb) up 3.4% as it launched its blockbuster weight-loss drug Wegovy in Germany.

The German DAX ended 0.1% lower, but hovered near record high levels hit recently.

Italy's FTSE MIB added 0.5% to touch fresh 15-year highs, lifted by the state-controlled defence and aerospace group Leonardo.

Limiting further upside on Monday, Heineken shares slid 8.0% after the world's second-largest brewer by volume cut its 2023 profit growth forecast as an economic slowdown in Vietnam depressed first-half earnings.

© Reuters. FILE PHOTO-The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, July 28, 2023. REUTERS/Staff

Heineken's peers Anheuser-Busch InBev and Carlsberg (CSE:CARLa) shed over 2% each.

An index of euro zone banks edged up 0.2% after the European Banking Authority's (EBA) annual stress test results showed three of 70 banks from the European Union failed to meet binding capital requirements.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.